Cargando…

Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors

Detalles Bibliográficos
Autores principales:	Rijo, Patricia, Athanassopoulos, Constantinos M., Carpinella, María Cecilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768599/ https://www.ncbi.nlm.nih.gov/pubmed/36569312 http://dx.doi.org/10.3389/fphar.2022.1108252

Ejemplares similares

Editorial: “Natural Products as a Tool to Design New anti-MDR Lead Molecules.”
por: Rijo, Patrícia, et al.
Publicado: (2021)

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
por: Reis, Mariana Alves, et al.
Publicado: (2020)

Inhibition of MurA Enzyme from Escherichia coli and Staphylococcus aureus by Diterpenes from Lepechinia meyenii and Their Synthetic Analogs
por: Funes Chabán, Macarena, et al.
Publicado: (2021)

Editorial: Natural compounds as scaffolds for the discovery of new anti-cancer drugs: Focus on terpenoids and flavonoids
por: Sülsen, Valeria P., et al.
Publicado: (2022)

Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
por: Viegas, Claudio, et al.
Publicado: (2020)

Editorial: Application of Plant Secondary Metabolites to Pain Neuromodulation
por: Singla, Rajeev K., et al.
Publicado: (2021)

Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy
por: Vazhappilly, Cijo George, et al.
Publicado: (2023)

Editorial: II Bio.natural-bioactive natural products research meeting: Pharmacology perspectives
por: Rijo, Patricia, et al.
Publicado: (2022)

Synthetic Lethal Activity of Benzophenanthridine Alkaloids From Zanthoxylum coco Against BRCA1-Deficient Cancer Cells
por: García, Iris A., et al.
Publicado: (2020)

Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer
por: Feng, Liang, et al.
Publicado: (2023)

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
por: Wang, Gangyang, et al.
Publicado: (2022)

Editorial: Application of plant secondary metabolites to pain neuromodulation, volume II
por: Singla, Rajeev K., et al.
Publicado: (2022)

Editorial: Application of plant secondary metabolites to pain neuromodulation, volume III
por: Singla, Rajeev K., et al.
Publicado: (2023)

Review on the Antibacterial Mechanism of Plant-Derived Compounds against Multidrug-Resistant Bacteria (MDR)
por: Jubair, Najwan, et al.
Publicado: (2021)

Antibacterial Properties of Medicinal Plants From Pakistan Against Multidrug-Resistant ESKAPE Pathogens
por: Khan, Muhammad Faraz, et al.
Publicado: (2018)

Antimicrobial activity of natural products against MDR bacteria: A scientometric visualization analysis
por: Zhou, Yan-Xi, et al.
Publicado: (2022)

Editorial: Therapeutic potential of plant-derived metabolites in spinal or sciatic injury-induced neuropathic pain
por: Khan, Abdul Waheed, et al.
Publicado: (2023)

Editorial: Novel Approaches to the Treatment of Multidrug-Resistant Bacteria
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Metabolic stability and metabolite profiling of emerging synthetic cathinones
por: Lopes, Rita P., et al.
Publicado: (2023)

Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition
por: Beaudoin, James J., et al.
Publicado: (2023)

Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites
por: El-Readi, Mahmoud Zaki, et al.
Publicado: (2021)

Editorial: Fungal Bioactive Metabolites of Pharmacological Relevance
por: Fasinu, Pius S., et al.
Publicado: (2022)

Phytochemicals: Potential Lead Molecules for MDR Reversal
por: Tinoush, Boshra, et al.
Publicado: (2020)

Editorial: Are natural products, used as antitumoral/antiangiogenic agents, less toxic than synthetic conventional chemotherapy?
por: Nunez, Cecilia Veronica, et al.
Publicado: (2022)

Editorial: Novel approaches to the treatment of multidrug-resistant bacteria, Volume II
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1
por: Gil, Florimar, et al.
Publicado: (2022)

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens
por: Behzadi, Payam, et al.
Publicado: (2022)

Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology
por: Pichini, Simona, et al.
Publicado: (2019)

Editorial: Pharmacokinetic Evaluation and Modeling of Clinically Significant Drug Metabolites
por: Mircioiu, Constantin, et al.
Publicado: (2021)

Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens
por: Thomson, Kenneth S., et al.
Publicado: (2019)

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
por: Miltyk, Wojciech, et al.
Publicado: (2022)

Editorial: Plant-based drugs: the potential novel therapeutic intervention against cancer stemness and metastasis
por: Liju, Vijayasteltar B., et al.
Publicado: (2023)

Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges
por: Swain, Shasank Sekhar, et al.
Publicado: (2023)

Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China
por: Sun, Yanni, et al.
Publicado: (2015)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)

Multidrug resistance (mdr) genes in human cancer.
por: Nooter, K., et al.
Publicado: (1991)

Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment
por: Vaidya, Niteen A., et al.
Publicado: (2020)

Editorial: Cosmeceuticals From Medicinal Plants
por: Lall, Namrita, et al.
Publicado: (2020)

Editorial: Plant products for antiviral therapeutics
por: Mandal, Anirban, et al.
Publicado: (2022)

Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions
por: Alam, Safaet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jtt4h61rbofu24ba8dh6b1ighk